India's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...

A gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...

Indian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...

Houston, Texas is leading corporate headquarters relocations, attracting 192 companies since 2018. Businesses are leaving California due to...

Bio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...

According to industry executives, the modest price hike of 0.6% that the government has allowed on essential medicines effective April 1 is...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...

The Supreme Court upheld NPPA's Rs 4.65 crore recovery from Sun Pharma for Roscilox overpricing (April 1996 - July 2003). The appeal was re...

People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying coun...

"The larger mandate of the NPPA was to seal the MRP keeping in view the margins allowed under the Drug Price Control Order to the wholesale...

Both the drug associations and pharma companies responsible for mandating the requirement of obtaining NOC prior to the appointment

Stockists, worried they may suffer losses on account of a possible mismatch between tax payouts and tax refunds once GST kicks in, have sta...

A committee set up under the department of pharmaceuticals will study the extent of margins on medicine brands that are supplied to traders...

Several mid-sized Indian drug makers heavily dependent on the United States are beginning to suffer because consolidation in the US pharmac...

Pharmaceutical companies and distributors have decided to calculate “loss to trade channels” on account of the new pricing policy.